Anebulo Pharmaceuticals Inc (ANEB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANEB | AZN | AMGN | GILD | VRTX |
| Company | Anebulo Pharmaceuticals Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.5800 | 71.14 | 292.17 | 108.85 | 451.26 |
| High | 1.5900 | 71.14 | 294.55 | 110.16 | 451.81 |
| Low | 1.4300 | 69.66 | 288.54 | 107.30 | 436.80 |
| Last | 1.5400 | 69.95 | 289.33 | 108.50 | 440.87 |
| Change | -0.0100 | -0.81 | -0.30 | +0.50 | -7.53 |
| % Change | -0.65% | -1.14% | -0.10% | +0.46% | -1.68% |
| Volume | 8,200 | 6,297,100 | 6,801,300 | 23,268,102 | 2,167,400 |
| 20-Day Average Volume | 7,320 | 4,104,235 | 2,751,285 | 8,602,160 | 1,354,240 |
| Previous Close | 1.5500 | 70.76 | 289.63 | 108.00 | 448.40 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.2040 | 72.13 | 287.40 | 109.64 | 446.51 |
| 20-Day Raw Stochastic | 78.31% | 8.12% | 66.57% | 36.78% | 40.85% |
| 20-Day Relative Strength | 66.32% | 45.67% | 52.41% | 51.21% | 44.26% |
| Weighted Alpha | -62.38 | -10.58 | -6.10 | +48.03 | -8.05 |
| Today's Opinion | 8% Buy | 16% Sell | 24% Sell | 72% Buy | 88% Sell |
| Previous Opinion | 8% Buy | 8% Buy | 24% Sell | 72% Buy | 72% Sell |
| Last Month's Opinion | 100% Sell | 72% Sell | 72% Sell | 64% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +21.26% since 06/12/25 | -6.73% since 06/12/25 | -2.68% since 06/12/25 | -3.17% since 06/12/25 | -4.17% since 06/12/25 |
| Low | 1.2175 on 06/13/25 | 69.66 on 06/20/25 | 286.60 on 06/18/25 | 107.19 on 06/18/25 | 436.80 on 06/20/25 |
| High | 1.6900 on 06/17/25 | 74.98 on 06/13/25 | 299.49 on 06/13/25 | 111.78 on 06/18/25 | 460.10 on 06/13/25 |
| 1-Month | |||||
| %Chg | +52.46% since 05/20/25 | +0.04% since 05/20/25 | +5.21% since 05/20/25 | -0.56% since 05/20/25 | -1.41% since 05/20/25 |
| Low | 0.9985 on 05/30/25 | 69.47 on 05/22/25 | 269.10 on 05/22/25 | 105.58 on 05/23/25 | 427.43 on 05/23/25 |
| High | 1.6900 on 06/17/25 | 75.38 on 06/12/25 | 299.49 on 06/13/25 | 113.52 on 06/09/25 | 460.33 on 06/11/25 |
| 3-Month | |||||
| %Chg | -22.22% since 03/20/25 | -8.59% since 03/20/25 | -8.16% since 03/20/25 | +2.48% since 03/20/25 | -13.59% since 03/20/25 |
| Low | 0.9001 on 04/09/25 | 61.24 on 04/09/25 | 261.43 on 05/14/25 | 93.37 on 04/25/25 | 416.60 on 05/14/25 |
| High | 2.0100 on 03/21/25 | 75.90 on 03/21/25 | 317.58 on 03/24/25 | 114.75 on 04/03/25 | 513.97 on 03/24/25 |
| 6-Month | |||||
| %Chg | +55.56% since 12/20/24 | +7.04% since 12/20/24 | +9.85% since 12/20/24 | +17.21% since 12/20/24 | +10.97% since 12/20/24 |
| Low | 0.9001 on 04/09/25 | 61.24 on 04/09/25 | 257.05 on 01/06/25 | 88.57 on 01/10/25 | 390.92 on 12/23/24 |
| High | 2.1900 on 03/19/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 63,271 | 216,937,040 | 155,574,464 | 134,966,288 | 113,214,088 |
| Shares Outstanding, K | 41,085 | 3,101,316 | 537,706 | 1,243,929 | 256,797 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -8,200,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 13,588,000,000 | 8,149,000,000 | 6,667,000,000 | 2,770,200,000 |
| Last Quarter Net Income | -1,680,000 | 2,921,000,000 | 1,730,000,000 | 1,315,000,000 | 646,300,000 |
| 60-Month Beta | -1.15 | 0.38 | 0.51 | 0.29 | 0.41 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.04 on 05/13/25 | 1.24 on 04/29/25 | 4.90 on 05/01/25 | 1.81 on 04/24/25 | 4.06 on 05/05/25 |
| Latest Earnings Date | 05/21/25 | 07/24/25 | 08/05/25 | 08/14/25 | 08/07/25 |
| Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 05/16/25 | 0.790 on 06/13/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 06/13/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.19 | 13.94 | 14.02 | 0.00 |